JENNIFER AZELTON: Open Payments
NPI 1295247401 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 24 payments from 10 companies in 2025. Trend: 2023 $238 · 2024 $1,119 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $137 |
| Madrigal Pharmaceuticals | 3 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $52 |
| Boston Scientific Corporation | 1 | $52 |
| Janssen Biotech, Inc. | 2 | $37 |
| QOL Medical, LLC | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $20 |
Products named: REZDIFFRA, CREON, IQIRVO, Rezum Generator, ENTYVIO, TREMFYA, SKYRIZI, RINVOQ.
Industry payments across GA — which companies pay providers there.
